- Agilent Technologies has agreed to acquire clinical pathology company Biocare Medical in an all-cash transaction valued at $950 million.
- The acquisition is intended to expand Agilent’s pathology diagnostics portfolio, including immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH) technologies.
Agilent Technologies has entered into a definitive agreement to acquire Biocare Medical from an investor group led by Excellere Partners and GHO Capital Partners LLP in an all-cash transaction valued at $950 million. The deal is expected to close by no later than Agilent’s fourth fiscal quarter of 2026, subject to customary closing conditions and regulatory approvals.
Biocare Medical develops and supplies pathology antibodies and diagnostic solutions used in clinical and research laboratories. Its portfolio includes more than 300 specialized antibodies and technologies such as immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH). The company reported more than $90 million in revenue in 2025 and has recorded double-digit revenue and profit growth since 2021.
The acquisition is intended to expand Agilent’s pathology diagnostics portfolio and strengthen its offering for pathology laboratories. By combining Agilent’s global operations with Biocare’s commercial presence in the United States, the companies aim to broaden access to diagnostic tools used in cancer testing and clinical pathology.
“The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth through customer-centric innovation and disciplined capital allocation.”
Padraig McDonnell, President and CEO of Agilent
Following completion of the transaction, Biocare Medical will become part of the Agilent Life Sciences and Diagnostics Markets Group. Agilent stated that the acquisition is expected to contribute to revenue growth and margin performance while expanding its portfolio of antibodies, reagents, and diagnostic instruments used in clinical testing and research.
